home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

118 rows where has_known_aptamer = 1 and surface_class = "A2_pm_peripheral" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: aptamer_count_pubmed

tier 2

  • Tier 1 78
  • Tier 1.5 40

in_cev_map 2

  • 1 82
  • 0 36

has_structure 2

  • 1 99
  • 0 19

has_cryoEM 2

  • 0 95
  • 1 23

has_activation_state_pdb_pair 2

  • 0 116
  • 1 2

surface_class 1

  • A2_pm_peripheral · 118 ✖

has_known_aptamer 1

  • 1 · 118 ✖
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P15056 BRAF Serine/threonine-protein kinase B-raf Tier 1 0.803 1 A2_pm_peripheral 100 66.38 0 0     1 6 39624124, 34874026, 33497198, 31726389, 24486214, 11856330 1 cardiofaciocutaneous syndrome 0.8764542776642054
P04049 RAF1 RAF proto-oncogene serine/threonine-protein kinase Tier 1 0.799 1 A2_pm_peripheral 75 67.5 0 0     1 4 15112994, 12173045, 11856330, 9883908 1 Noonan syndrome 0.8625147809861142
Q06187 BTK Tyrosine-protein kinase BTK Tier 1 0.794 1 A2_pm_peripheral 100 84.44 0 0     1 1 41951939 1 X-linked agammaglobulinemia 0.8454716106068291
O60315 ZEB2 Zinc finger E-box-binding homeobox 2 Tier 1.5 0.789 1 A2_pm_peripheral 1 48.16 0 0     1 3 27719642, 24146916, 18698484 1 Mowat-Wilson syndrome 0.8313744323041312
Q02750 MAP2K1 Dual specificity mitogen-activated protein kinase kinase 1 Tier 1 0.788 1 A2_pm_peripheral 94 83.25 0 0     1 1 29580944 1 cardiofaciocutaneous syndrome 0.825549979325162
P11274 BCR Breakpoint cluster region protein Tier 1.5 0.785 1 A2_pm_peripheral 5 64.81 0 0     1 20 41951939, 41535871, 40882628, 37937247, 37103734, 32929022, 32507237, 31825964, 31650445, 31295447, 29299123, 28686804, 25809097, 23836560, 22411871, 21810089, 21653319, 21030439, 16990253, 11713794 1 chronic myelogenous leukemia 0.8183048540102864
P01111 NRAS GTPase NRas Tier 1 0.783 1 A2_pm_peripheral 35 92.06 0 0     1 2 39952900, 39371477 1 Noonan syndrome 6 0.8087775198380727
O60674 JAK2 Tyrosine-protein kinase JAK2 Tier 1 0.78 1 A2_pm_peripheral 100 86.88 0 0     1 8 41455398, 34121564, 32985358, 31279934, 30415442, 25809097, 22411871, 20711698 1 polycythemia vera 0.8000866241942614
P01137 TGFB1 Transforming growth factor beta-1 proprotein Tier 1 0.78 1 A2_pm_peripheral 20 79.56 1 0     1 4 38132522, 32370304, 16775010, 11856769 1 Camurati-Engelmann disease 0.7995305374459716
P98170 XIAP E3 ubiquitin-protein ligase XIAP Tier 1 0.78 1 A2_pm_peripheral 74 74.25 0 0     1 4 35383192, 29864441, 27514505, 26318819 1 X-linked lymphoproliferative disease 0.8013347966323413
Q9UHD9 UBQLN2 Ubiquilin-2 Tier 1 0.778 1 A2_pm_peripheral 4 61.03 0 0     1 2 23541532 1 amyotrophic lateral sclerosis type 15 0.7942015735994536
Q9ULC3 RAB23 Ras-related protein Rab-23 Tier 1.5 0.776 1 A2_pm_peripheral 6 79.56 1 0     1 1 23618401 1 RAB23-related Carpenter syndrome 0.7879955689930709
O15294 OGT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit Tier 1 0.77 1 A2_pm_peripheral 44 93.06 0 0     1 2 36868188, 36626902 1 intellectual disability, X-linked 106 0.7660009745204424
P55263 ADK Adenosine kinase Tier 1.5 0.769 1 A2_pm_peripheral 4 93.31 0 0     1 2 26051465 1 adenosine kinase deficiency 0.7617058236708037
Q92743 HTRA1 Serine protease HTRA1 Tier 1 0.768 1 A2_pm_peripheral 18 83.25 1 0     1 1 31988066 1 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 0.7611877816680132
P35221 CTNNA1 Catenin alpha-1 Tier 1 0.765 1 A2_pm_peripheral 10 82.94 1 0     1 2 40265971 1 Butterfly-shaped pigment dystrophy 0.7487735496199569
P26038 MSN Moesin Tier 1 0.755 1 A2_pm_peripheral 10 86.38 0 0     1 65 41813080, 41784619, 41611946, 40904334, 40886652, 40258621, 40222299, 39454415, 39053429, 38856817, 38759442, 38687941, 38561432, 38446130, 38349197, 38295649, 38266273, 37869770, 37806507, 37423650, 37353120, 37062561, 37058944, 36982925, 36843953, 36700559, 36562728, 36179642, 35026109, 34893239, 34538325, 33960345, 33727809, 33528465, 33149582, 32882423, 32291531, 32170403, 31872318, 31792209, 31213813, 31072481, 30985076, 30865739, 32254866, 29955964, 29568450, 29136862, 28917759, 28832225 1 combined immunodeficiency due to moesin deficiency 0.7157135146765757
P84077 ARF1 ADP-ribosylation factor 1 Tier 1 0.755 1 A2_pm_peripheral 36 85.94 1 0     1 3 30965174, 11320245 1 periventricular nodular heterotopia 8 0.7173626622431929
Q13153 PAK1 Serine/threonine-protein kinase PAK 1 Tier 1 0.753 1 A2_pm_peripheral 41 73.69 0 0     1 2 32636813, 20564698 1 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.7110292416229067
Q13546 RIPK1 Receptor-interacting serine/threonine-protein kinase 1 Tier 1 0.749 1 A2_pm_peripheral 39 69.75 1 0     1 2 41290466, 35919280 1 immunodeficiency 57 0.698121745966467
P35241 RDX Radixin Tier 1.5 0.749 1 A2_pm_peripheral 2 86.56 0 0     1 2 33253235, 30700648 1 hearing loss, autosomal recessive 0.6973070672344621
P50148 GNAQ Guanine nucleotide-binding protein G(q) subunit alpha Tier 1 0.748 1 A2_pm_peripheral 30 93.0 1 0     1 1 40015005 1 Sturge-Weber syndrome 0.6941111530708174
P61586 RHOA Transforming protein RhoA Tier 1 0.744 1 A2_pm_peripheral 100 93.56 0 0     1 4 25645980, 19389625, 12927206, 12123800 1 ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0.6804889074382072
Q00535 CDK5 Cyclin-dependent kinase 5 Tier 1 0.744 1 A2_pm_peripheral 10 91.56 0 0     1 4 33291667, 33200349 1 Alzheimer disease 0.6800338890220147
O95786 RIGI Antiviral innate immune response receptor RIG-I Tier 1 0.735 1 A2_pm_peripheral 44 85.19 1 0     1 6 34487794, 33253193, 32946572, 31600868, 26018150, 22127865 1 Singleton-Merten dysplasia 0.6485708110478319
P26196 DDX6 Probable ATP-dependent RNA helicase DDX6 Tier 1 0.734 1 A2_pm_peripheral 9 84.06 0 0     1 2 34132569 1 intellectual developmental disorder with impaired language and dysmorphic facies 0.6482686715821397
P12931 SRC Proto-oncogene tyrosine-protein kinase Src Tier 1 0.73 1 A2_pm_peripheral 78 83.44 0 1 1Y57 2SRC 1 19 40569566, 39664567, 38471488, 35928129, 35859339, 34757788, 34083659, 33530373, 32668060, 30970280, 28701145, 26458993, 25645980, 23842900, 22693611, 22323540, 18985031, 18682833, 12842895 1 cancer 0.6343904000453656
P61769 B2M Beta-2-microglobulin Tier 1 0.725 1 A2_pm_peripheral 100 94.06 0 0     1 15 41850110, 40373155, 38904251, 40658810, 35026285, 32631049, 29281176, 28960840, 25100729, 20616783, 19137104, 17878167 1 Immunodeficiency by defective expression of HLA class 1 0.6180318849819645
P23921 RRM1 Ribonucleoside-diphosphate reductase large subunit Tier 1 0.724 1 A2_pm_peripheral 12 92.25 1 0     1 1 21955496 1 non-small cell lung carcinoma 0.6122881671315019
P43405 SYK Tyrosine-protein kinase SYK Tier 1 0.723 1 A2_pm_peripheral 93 84.0 0 0     1 2 35782912, 31825964 1 immunodeficiency 82 with systemic inflammation 0.608506293550361
P06241 FYN Tyrosine-protein kinase Fyn Tier 1 0.721 1 A2_pm_peripheral 53 80.81 0 0     1 5 38559166, 37149826, 34757788, 32668060, 29754498 1 chronic myelogenous leukemia 0.6018224074412558
P32121 ARRB2 Beta-arrestin-2 Tier 1.5 0.719 1 A2_pm_peripheral 1 83.81 1 0     1 4 24736311, 40652239, 29054528 1 cancer 0.5962458729823639
P07947 YES1 Tyrosine-protein kinase Yes Tier 1 0.716 1 A2_pm_peripheral 1 81.88 0 0     1 1 34757788 1 chronic myelogenous leukemia 0.5851678597856559
P09769 FGR Tyrosine-protein kinase Fgr Tier 1.5 0.716 1 A2_pm_peripheral 3 82.19 0 0     1 1 39564692 1 chronic myelogenous leukemia 0.5869168331059803
P45984 MAPK9 Mitogen-activated protein kinase 9 Tier 1 0.707 1 A2_pm_peripheral 5 81.44 0 0     1 1 41505229 1 cancer 0.5569349147269519
P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase Tier 1 0.706 1 A2_pm_peripheral 21 98.12 1 0     1 11 39832592, 39429683, 35821507, 28131717, 26310631, 23215008, 37500700, 16115199 1 neurodegenerative disease 0.55307368855439
P42680 TEC Tyrosine-protein kinase Tec Tier 1.5 0.705 1 A2_pm_peripheral 1 85.0 0 0     1 13 39352470, 39329798, 36414190, 36105684, 35624657, 35462326, 35006795, 30578658, 30398689, 27548775, 26843427, 25016253, 24875764 1 alopecia areata 0.5491699656070116
O75534 CSDE1 Cold shock domain-containing protein E1 Tier 1 0.704 1 A2_pm_peripheral 5 79.56 0 0     1 1 10101203 1 neurodegenerative disease 0.5472997885061864
P17252 PRKCA Protein kinase C alpha type Tier 1.5 0.704 1 A2_pm_peripheral 6 86.38 0 0     1 1 41505229 1 acute myeloid leukemia 0.547429504944985
P67809 YBX1 Y-box-binding protein 1 Tier 1 0.703 1 A2_pm_peripheral 11 61.84 0 0     1 9 31989173, 31160337, 22730292, 21245151, 16093451 1 dengue disease 0.5435698373845997
P34947 GRK5 G protein-coupled receptor kinase 5 Tier 1 0.702 1 A2_pm_peripheral 23 90.38 0 0     1 1 18230760 1 venous thromboembolism 0.5394311062516939
Q92888 ARHGEF1 Rho guanine nucleotide exchange factor 1 Tier 1 0.695 1 A2_pm_peripheral 7 73.19 0 0     1 6 25645980, 23757206, 25033804, 22689339, 19389625, 12123800 1 immunodeficiency 62 0.5170912094162261
Q96PY5 FMNL2 Formin-like protein 2 Tier 1.5 0.695 1 A2_pm_peripheral 1 76.44 0 0     1 1 41149482 1 open-angle glaucoma 0.5157968177633478
P09543 CNP 2',3'-cyclic-nucleotide 3'-phosphodiesterase Tier 1.5 0.689 1 A2_pm_peripheral 1 87.25 0 0     1 9 40034273, 38569854, 37704353, 35528922, 31171207, 30089209, 27192549, 19021295 1 myopia 2, autosomal dominant 0.49606855995054094
P31948 STIP1 Stress-induced-phosphoprotein 1 Tier 1.5 0.689 1 A2_pm_peripheral 8 89.75 1 0     1 7 41406518, 38012811, 34831332, 32614006, 27681499, 24654750, 24013070 1 neurodegenerative disease 0.4967711525222825
P21980 TGM2 Protein-glutamine gamma-glutamyltransferase 2 Tier 1.5 0.688 1 A2_pm_peripheral 17 92.88 1 0     1 1 35980938 1 neurodegenerative disease 0.49455272812698803
P49327 FASN Fatty acid synthase Tier 1 0.68 1 A2_pm_peripheral 34 85.44 1 0     1 1 41854184 1 dengue disease 0.46815584653391107
Q07812 BAX Apoptosis regulator BAX Tier 1 0.679 1 A2_pm_peripheral 37 85.94 0 0     1 21 41323565, 41237573, 40761795, 40148451, 39946362, 39318128, 37301952, 36907299, 36843953, 36309655, 32987067, 32486412, 31747745, 30005287, 27843907, 26325285, 24481451, 23582862, 23528042, 21563784, 21362508 1 T-cell acute lymphoblastic leukemia 0.4626258720529755
P09104 ENO2 Gamma-enolase Tier 1 0.676 1 A2_pm_peripheral 16 97.06 0 0     1 1 36384120 1 neurodegenerative disease 0.4533558777394424
P07355 ANXA2 Annexin A2 Tier 1 0.673 1 A2_pm_peripheral 41 94.25 0 0     1 12 40685636, 31029658, 29906496, 24489826, 35211356, 29982617, 27890659, 27777972, 26061649 1 neurodegenerative disease 0.4424399692174707

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 429.143ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target